Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank36
3Y CAGR-25.7%
5Y CAGR-31.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-25.7%/yr
vs +11.0%/yr prior
5Y CAGR
-31.9%/yr
Recent acceleration
Acceleration
-36.7pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.85 | +8.1% |
| 2024 | 7.27 | -55.0% |
| 2023 | 16.17 | -15.7% |
| 2022 | 19.17 | -46.3% |
| 2021 | 35.71 | -33.6% |
| 2020 | 53.81 | +499.4% |
| 2019 | 8.98 | -29.0% |
| 2018 | 12.65 | +414.5% |
| 2017 | 2.46 | -34.0% |
| 2016 | 3.73 | - |